Expertise in
141
conditions

Dr. C M. Jones

Hematology Oncology | Hematology | Oncology
Baptist Cancer Center (Physicians)
200 State Highway 30 W, 
New Albany, MS 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
141
conditions
Baptist Cancer Center (Physicians)
200 State Highway 30 W, 
New Albany, MS 

Overview

C Jones is a Hematologist Oncology specialist and a Hematologist practicing medicine in New Albany, Mississippi.

Dr. Jones is highly rated in 141 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Protein C Deficiency, Congenital Antithrombin 3 Deficiency, Hereditary Resistance to Anti-Vitamin K, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 5 clinical trials. Dr. Jones is currently accepting new patients.

Specialties

Hematology Oncology
Hematology
Oncology

Licenses

Internal Medicine in MS

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Baptist Cancer Center (Physicians)
200 State Highway 30 W, New Albany, MS 38652

Additional Areas of Focus

Dr. Jones has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
Enrollment Status: Recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drugs: Glufosfamide, Fluorouracil
Study Phase: Phase 3
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Enrollment Status: Completed
Publish Date: June 03, 2024
A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
Enrollment Status: Terminated
Publish Date: November 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
Enrollment Status: No_longer_available
Publish Date: November 03, 2020
Intervention Type: Drug
View 4 Less Clinical Trials

3 Total Publications

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 19, 2018
Similar Doctors
Expertise in
55
conditions
Dr. Drew S. Dill
Hematology Oncology | Hematology | Oncology
Expertise in
55
conditions
Dr. Drew S. Dill
Hematology Oncology | Hematology | Oncology
Referral may be required
Before you request

Baptist Memorial Medical Group Inc

1500 W Poplar Ave Ste 308, 
Collierville, TN 
 (52.8 miles away)
901-861-8550
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Drew Dill is a Hematologist Oncology specialist and a Hematologist practicing medicine in Collierville, Tennessee. Dr. Dill is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Dill is currently accepting new patients.

Expertise in
45
conditions
Dr. Clayton C. Allen
Hematology Oncology | Hematology | Oncology
Expertise in
45
conditions
Dr. Clayton C. Allen
Hematology Oncology | Hematology | Oncology
Referral may be required
Before you request

Family Cancer Center PLLC

504 Azalea Dr Ste A, 
Oxford, MS 
 (27.8 miles away)
662-236-7738
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Clayton Allen is a Hematologist Oncology specialist and a Hematologist practicing medicine in Oxford, Mississippi. Dr. Allen is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Angiosarcoma, Familial Colorectal Cancer, and Familial Pancreatic Cancer. Dr. Allen is currently accepting new patients.

Expertise in
22
conditions
Dr. Brent A. Mullins
Hematology Oncology
Expertise in
22
conditions
Dr. Brent A. Mullins
Hematology Oncology
Referral may be required
Before you request

Russell Medical Clinic

402 Doctors Dr, 
New Albany, MS 
 (0.2 miles away)
662-538-5526
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brent Mullins is a Hematologist Oncology provider practicing medicine in New Albany, Mississippi. Dr. Mullins is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast. Dr. Mullins is currently accepting new patients.

Frequently Asked Questions about Dr. C M. Jones

How do I make an appointment with Dr. C M. Jones?

You can book an appointment with Dr. C M. Jones by calling their office at 662-538-2535. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. C M. Jones a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. C M. Jones is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. C M. Jones specialize in?

While Dr. C M. Jones is a Hematology Oncology, they have specific expertise in Paget Disease of the Breast, Protein C Deficiency, and Congenital Antithrombin 3 Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. C M. Jones participate in research or clinical trials?

Yes. Dr. C M. Jones has published 3 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. C M. Jones's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. C M. Jones accept my insurance?

Dr. C M. Jones accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 662-538-2535 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jones's expertise for a condition
ConditionClose
    View All 18 Distinguished Conditions
    View All 123 Advanced Conditions
    View All 149 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile